Power spectral analysis of visual evoked potentials in multiple sclerosis

Area of Science:

• Neuroscience
• Ophthalmology
• Neurology

Background:

• Multiple Sclerosis (MS) is a demyelinating disease affecting the central nervous system.
• Visual pathway abnormalities are common in MS, impacting visual evoked potentials (VEPs).
• Traditional VEP analysis focuses on latency, but waveform abnormalities can complicate diagnosis.

Purpose of the Study:

• To evaluate the utility of Power Spectral Analysis (PSA) in detecting visual pathway abnormalities in MS.
• To assess the combined diagnostic value of PSA and VEP latency.
• To improve the detection rate of MS-related visual dysfunction, particularly in cases with waveform deformities.

Main Methods:

• Power spectral analysis (PSA) was applied to transient visual evoked potentials (VEPs).
• VEPs were elicited using counterphased checkerboard stimuli.
• Data were collected from 98 eyes of 49 MS patients and 54 eyes of 27 normal volunteers.

Main Results:

• Attenuation of high-frequency components in VEPs was observed in 53% of MS patients versus 4% of controls.
• Loss of high-frequency components showed a weak correlation with prolonged VEP latency (r = 0.346).
• Combining PSA with latency analysis increased the detection of visual pathway abnormalities in MS patients from 61% to 86%.

Conclusions:

• PSA is a valuable tool for detecting high-frequency VEP abnormalities in MS.
• The integration of PSA enhances the diagnostic sensitivity for MS-related visual pathway conduction deficits.
• PSA improves MS detection, especially when VEP latency estimation is unreliable due to waveform distortion.